Creating a Healthier Asia Video Series

This is the journey we work with community partners in Asia to eliminate chronic diseases such as hepatitis B, hepatitis C, human immunodeficiency virus (HIV) and COVID-19.

The videos were produced with support from South China Morning Post (SCMP)’s Morning Studio.


Prioritizing Patients First Collaboration During the Pandemic

The spread of the coronavirus has strained healthcare systems across Asia, affecting patients with chronic conditions as their treatments get delayed. To ensure that no condition gets sidelined during the pandemic, patients-first collaboration is critical.


Overcoming HIV Stigma through Community Empowerment

Asia sees one of the highest number of people living with HIV. Yet, public prejudice and mistaken beliefs remain commonplace. Thankfully, major advances in prevention and treatments, such as the concept of “Undetectable = Untransmissible” has allowed people living with the virus to overcome social stigma.


Enhancing Health Education to Eliminate Viral Hepatitis – The “Silent Killers”

Hepatitis C is often known as a ‘silent killer’ as most people infected are either asymptomatic or unaware of their condition. Gilead aims to bolster health education and targeted screening, to realize the World Health Organization’s goal of halting 90% of new hepatitis C infections and 65% of hepatitis C deaths by 2030.


Working Together to Eradicate Hepatitis B

Hepatitis B is another virus that often goes undiagnosed. While the Asia Pacific region sees the highest prevalence of viral hepatitis, more than half of those living with hepatitis do not know they have the virus. Enhanced knowledge, early testing and proactive health monitoring is therefore key.